Felbamate as add-on therapy

European Neurology

Volumn 36, Issue 3, 1996, Pages 146-148

  Li, L M ^a,b   Nashef, L ^a,b   Moriarty, J ^a,b   Duncan, J S ^a,b   Sander, J W A S ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b EPILEPSY SOCIETY   (United Kingdom)

Author keywords

Behaviour disturbances; Epilepsy; Felbamate; New anti epileptic drugs

Indexed keywords

ANTICONVULSIVE AGENT; FELBAMATE;

ADULT; APLASTIC ANEMIA; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; FOLLOW UP; HEADACHE; HUMAN; INSOMNIA; LIVER FAILURE; MAJOR CLINICAL STUDY; MOOD; NAUSEA; PAIN; PRIORITY JOURNAL; RASH; SEIZURE; VERTIGO; VOMITING;

ADULT; ANEMIA, APLASTIC; ANTICONVULSANTS; EPILEPSY; FOLLOW-UP STUDIES; HUMANS; LIVER FAILURE; PROPYLENE GLYCOLS;

EID: 0029875521     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000117232     Document Type: Article

References (17)

1. Ahmad SR: Felbamate and aplastic anaemia (letter). Lancet 1994,344:465.
2. Rho JM, Donevain SD, Rogawski MA: Mechanism of action of the anticonvulsant felbamate. Opposite effects on N-methyl-D-aspartate and GABA, I receptors. Ann Neurol 1994:35:229-234.
3. Gordon R, Gels M, Wiehmann J, Diamantis W, Sofia RD: Interaction of felbamate with several other anticpileptic drugs against seizures induced by maximal electroshock in mice. Epilepsia 1993:34:367-371.
4. Swinyard EA, Sofia RK, Kuptferberg HJ: Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepi-lcptic drugs in mice and rats. Epilepsia 1986; 27:27-34.
5. Fuerst RH, Graves NM, Leppik IE, Brundage RC, Holmes GB, Remmel RP: Felbamate increases phenytoin but decreases carbamazc-pine concentrations. Epilepsia 1988;29:488-491.
6. Graves NM, Holmes GB, Fuerst RH, Leppik IE: Effect of fclbamate on phenytoin and carba-mazepine serum concentrations. Epilepsia 1989;30:225-229.
7. Albani F, Theodore WH, Washington P, De-vinsky O, Bromfield E, Porter RJ, Nice FJ: Effect of felbamate on plasma levels of carba-mazepinc and its metabolites. Epilepsia 1991; 32:130-132.
8. Gidal BE, Zupane ML: Potential pharmacokinetic interaction between felbamate and phénobarbital. Ann Pharmacother 1994:28:455-458.
9. Commission on Classification and terminology of the International League Against Epilepsy: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30: 389-399.
10. Theodore WH, Raubertas RF, Porter RJ, Nice F, Devinskv O, Reeves P, Bromfield E, Ito B. Balsih M: Felbamate: A clinical trial for complex partial seizures. Epilepsia 1991;32:392-397.
11. Leppik IE, Dreifuss FE, Pledger GW, Graves NM, Santilli N, Drury I, Tsay JY, Jacobs MP, Bertram E, Cereghino JJ: Felbamate for partial seizures: Results of a controlled clinical trial. Neurology 1991;41:1785-1789.
12. Faught E, Sachdco RC, Remler MP, Chayasiri-sobhon S, Iragui-Madoz VJ, Ramsey RE, Sutu-la TP, Kanner A, Harner RN, Kuzniecky R, Kramer LD, Kamin M, Rosenberg A: Fclba-mate monotherapy for partial-onset seizures: An active-control trial. Neurology 1993;43: 688-692.
13. Sachdeo R, Kramer LD, Rosenberg A, Sachdeo SI: Felbamate monotherapy: Controlled trial in patients with partial onset seizures. Ann Neurol 1992;32:386-392.
14. Bourgeois BFD, Leppik IE, Sackellares JC, Laxer K, Lesser R, Messcnheimer JA, Kramer LD, Kamin M, Rosenberg A: Felbamate: A double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology 1993;43:693-696.
15. The felbamate study group in Lennox-Gastaut syndrome. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). N Engl J Med 1993:328:29-33.
16. Chadwick D, Schmidt D (eds): Felbamate: A new compound for the treatment of epilepsy. Epilepsia 1993;34(suppl 7):S1-S33.
17. Devinsky O, Kothari M, Savinol L, Luciano D: Felbamate for refractory absence seizures. J Epilepsy 1994;7:189-194.